Kite Pharma Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 4,025


  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $11.2B

  • Investors
  • 1

Kite Pharma General Information


Operator of a clinical-stage biopharmaceutical company intended to bring the promise of cell therapy to cancer patients. The company focuses on the development and commercialization of novel cancer immunotherapy products designed to harness the power of a patient's own immune system to eradicate cancer cells.

Contact Information

Ownership Status
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Other Industries
Drug Discovery
Parent Company
Corporate Office
  • 2400 Broadway
  • Santa Monica, CA 90404
  • United States
+1 (310) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Kite Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Merger/Acquisition 03-Oct-2017 $11.2B 00000 000.00 Completed Generating Revenue
5. Secondary Transaction - Open Market 01-Apr-2015 00000 Completed Generating Revenue
4. IPO 20-Jun-2014 00000 00000 00000 Completed Generating Revenue
3. Mezzanine 28-Apr-2014 0000 0000 Completed Clinical Trials - Phase 2
2. Early Stage VC (Series A) 15-May-2013 $35M $35M 00000 Completed Clinical Trials - Phase 2
1. Spin-Off 01-Jan-2009 Completed Startup
To view Kite Pharma’s complete valuation and funding history, request access »

Kite Pharma Cap Table

Stock # of Shares
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
To view Kite Pharma’s complete cap table history, request access »

Kite Pharma Comparisons

HQ Location
Total Raised
Post Valuation
Operator of a clinical-stage biopharmaceutical company intended to bring the promise of cell therapy to cancer patients.
Santa Monica, CA
4,025 As of 2023
000.00 0000-00-00
000000&0 00000


piscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
Gaithersburg, MD
00 As of 0000
00000000 00000


, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo conseq
Utrecht, Netherlands
00 As of 0000
000000&0 00.000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Kite Pharma Competitors (47)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
NexImmune Formerly VC-backed Gaithersburg, MD 00 00000 00000000 00000
Gadeta Formerly VC-backed Utrecht, Netherlands 00 00.000 000000&0 00.000
Carisma Therapeutics Formerly VC-backed Philadelphia, PA 000 00000 000000000 00000
Adimab Venture Capital-Backed Lebanon, NH 000 00000 0000000000 0 00000
CureVac Formerly VC-backed Tubingen, Germany 0000 00.000 00000000 00.000
You’re viewing 5 of 47 competitors. Get the full list »

Kite Pharma Patents

Kite Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20240076117-A1 Systems and methods for shipping cryogenically-frozen materials Pending 01-Sep-2022 000000000
US-20240091261-A1 Immune cell function Pending 26-Aug-2022 000000000
US-20230399614-A1 Methods of preparing lymphocytes for cell therapy Pending 09-Jun-2022 0000000000
US-20230392119-A1 Compositions and methods for preparing engineered lymphocytes for cell therapy Pending 27-May-2022 0000000000
US-20240000844-A1 Non-viral delivery of cell therapy constructs Pending 27-May-2022 A61K35/17
To view Kite Pharma’s complete patent history, request access »

Kite Pharma Executive Team (23)

Name Title Board Seat Contact Info
Francesco Marincola MD Executive, Research & Global Head of Cell Therapy Research
Prentice Curry Senior Vice President, Quality and Compliance
You’re viewing 2 of 23 executive team members. Get the full list »

Kite Pharma Board Members (9)

Name Representing Role Since
Roy Doumani Kite Pharma Independent Director 000 0000
You’re viewing 1 of 9 board members. Get the full list »

Kite Pharma Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Kite Pharma Former Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Arie Belldegrun Angel (individual) Minority 000 0000 000000 0
BB Biotech Asset Manager Minority 000 0000 000000 0
Bellco Capital PE/Buyout Minority 000 0000 000000 0
Bloom8 Venture Capital Minority 000 0000 000000 0
Commercial Street Capital Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 12 investors. Get the full list »

Kite Pharma Investments & Acquisitions (13)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Arcellx 15-Dec-2023 0000 00000 Drug Discovery
Tmunity 22-Feb-2023 0000000000 00.00 Biotechnology
Shoreline Biosciences 02-Nov-2021 00000 0000 00000 Drug Discovery
Appia Bio 11-May-2021 00000 0000 0000 Drug Discovery
Orna Therapeutics 24-Feb-2021 Early Stage VC 0000 Drug Delivery 000000000
You’re viewing 5 of 13 investments and acquisitions. Get the full list »

Kite Pharma Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
Gadeta 19-Jul-2018 00000 00000 00 Completed
  • 0000 000000
To view Kite Pharma’s complete exits history, request access »

Kite Pharma FAQs

  • When was Kite Pharma founded?

    Kite Pharma was founded in 2009.

  • Who is the founder of Kite Pharma?

    Joshua Kazam is the founder of Kite Pharma.

  • Where is Kite Pharma headquartered?

    Kite Pharma is headquartered in Santa Monica, CA.

  • What is the size of Kite Pharma?

    Kite Pharma has 4,025 total employees.

  • What industry is Kite Pharma in?

    Kite Pharma’s primary industry is Biotechnology.

  • Is Kite Pharma a private or public company?

    Kite Pharma is a Private company.

  • What is the current valuation of Kite Pharma?

    The current valuation of Kite Pharma is 000.00.

  • What is Kite Pharma’s current revenue?

    The current revenue for Kite Pharma is 000000.

  • How much funding has Kite Pharma raised over time?

    Kite Pharma has raised $212M.

  • Who are Kite Pharma’s investors?

    Arie Belldegrun, BB Biotech, Bellco Capital, Bloom8, and Commercial Street Capital are 5 of 12 investors who have invested in Kite Pharma.

  • Who are Kite Pharma’s competitors?

    NexImmune, Gadeta, Carisma Therapeutics, Adimab, and CureVac are some of the 47 competitors of Kite Pharma.

  • When was Kite Pharma acquired?

    Kite Pharma was acquired on 03-Oct-2017.

  • Who acquired Kite Pharma?

    Kite Pharma was acquired by Gilead Sciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »